Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 579.67% | -- | -99.01% | -99.01% | -99.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 579.67% | -- | -99.01% | -99.01% | -99.02% |
| Cost of Revenue | -30.01% | -18.68% | 55.74% | 55.74% | 291.43% |
| Gross Profit | 51.85% | 33.79% | -131.33% | -131.33% | -129.46% |
| SG&A Expenses | -5.73% | -8.67% | -9.36% | -0.08% | 1.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.13% | -11.92% | 0.09% | 1.70% | 2.33% |
| Operating Income | 19.18% | 16.11% | -1,083.05% | -1,671.98% | -1,931.32% |
| Income Before Tax | 20.38% | -131.21% | -351.17% | -552.73% | -568.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.38% | -131.21% | -351.17% | -552.73% | -568.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.38% | -131.21% | -351.17% | -552.73% | -568.67% |
| EBIT | 19.18% | 16.11% | -1,083.05% | -1,671.98% | -1,931.32% |
| EBITDA | 20.47% | 16.84% | -938.01% | -1,350.22% | -1,519.59% |
| EPS Basic | 24.21% | -148.15% | -290.85% | -437.11% | -487.76% |
| Normalized Basic EPS | 21.30% | -9.90% | -6,066.67% | -639.29% | -521.62% |
| EPS Diluted | 24.21% | -148.15% | -290.85% | -437.11% | -487.76% |
| Normalized Diluted EPS | 21.30% | -9.90% | -6,066.67% | -639.29% | -521.62% |
| Average Basic Shares Outstanding | 3.71% | 4.22% | 4.74% | 7.31% | 10.26% |
| Average Diluted Shares Outstanding | 3.71% | 4.22% | 4.74% | 7.31% | 10.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |